[JSPR] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[JSPR] Jasper Therapeutics, Inc.
Announcement Date
13-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -6.23%
YoY- 9.31%
Quarter Report
JSPR's Result
JSPR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 0 0 0 0 -
PBT -14,583 -16,080 -10,404 -8,414 -9,423 11.52%
Tax -299 -1,856 -1,559 -4 1 -
NP -14,583 -16,080 -8,845 -8,414 -9,423 11.52%
Tax Rate - - - - - -
Total Cost 14,583 16,080 8,845 8,414 9,423 11.52%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.97 -1.47 -0.24 -0.22 -16.08 -50.41%
EPS Diluted -0.97 -1.47 -0.24 -0.22 -16.06 -50.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.